Healthcare provider profile · identity verified

Kelly Andre Jarrett, M.D.

Family Practice · BROOKLYN, NY · NPI 1124339080

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1041	286
Amlodipine Besylate	Amlodipine Besylate	453	144
Albuterol Sulfate Hfa	Albuterol Sulfate	448	101
Losartan Potassium	Losartan Potassium	324	97
Rosuvastatin Calcium	Rosuvastatin Calcium	271	93
Januvia	Sitagliptin Phosphate	268	47
Chlorthalidone	Chlorthalidone	265	64
Metoprolol Succinate	Metoprolol Succinate	253	65
Gabapentin	Gabapentin	249	59
Nifedipine Er	Nifedipine	241	56
Varenicline Tartrate	Varenicline Tartrate	224	45
Farxiga	Dapagliflozin Propanediol	217	46
Tamsulosin Hcl	Tamsulosin Hcl	203	46
Famotidine	Famotidine	190	50
Lisinopril	Lisinopril	183	50
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	173	34
Metformin Hcl	Metformin Hcl	171	48
Furosemide	Furosemide	170	33
Fluticasone Propionate	Fluticasone Propionate	160	48
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	156	43
Eliquis	Apixaban	155	26
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	146	24
Diclofenac Sodium	Diclofenac Sodium	140	49
Jardiance	Empagliflozin	128	19
Pantoprazole Sodium	Pantoprazole Sodium	126	44
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	122	48
Omeprazole	Omeprazole	110	25
Ozempic	Semaglutide	110	22
Clopidogrel	Clopidogrel Bisulfate	101	24
Spiriva Respimat	Tiotropium Bromide	99	21
Enalapril Maleate	Enalapril Maleate	93	26
Alcohol Prep Pads	Alcohol Antiseptic Pads	89	21
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	87	22
Incruse Ellipta	Umeclidinium Bromide	85	20
Combivent Respimat	Ipratropium/Albuterol Sulfate	83	14
Donepezil Hcl	Donepezil Hcl	80	18
Levothyroxine Sodium	Levothyroxine Sodium	77	19
Metformin Hcl Er	Metformin Hcl	77	32
Metoprolol Tartrate	Metoprolol Tartrate	76	20
Lactulose	Lactulose	69	33
Prednisone	Prednisone	69	36
Alendronate Sodium	Alendronate Sodium	66	22
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	66	17
Citalopram Hbr	Citalopram Hydrobromide	64	13
Doxycycline Hyclate	Doxycycline Hyclate	64	31
Bupropion Hcl Sr	Bupropion Hcl	63	16
Simvastatin	Simvastatin	63	20
Entresto	Sacubitril/Valsartan	62	12
Hydralazine Hcl	Hydralazine Hcl	61	17
Montelukast Sodium	Montelukast Sodium	60	14
Trulicity	Dulaglutide	59	suppressed
Spironolactone	Spironolactone	55	13
Finasteride	Finasteride	52	14
Trazodone Hcl	Trazodone Hcl	52	12
Glipizide Er	Glipizide	51	16
Vitamin D2	Ergocalciferol (Vitamin D2)	50	24
Carvedilol	Carvedilol	47	19
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	46	suppressed
Valsartan	Valsartan	41	14
Nitroglycerin	Nitroglycerin	40	11
Symbicort	Budesonide/Formoterol Fumarate	40	11
Triamcinolone Acetonide	Triamcinolone Acetonide	40	23
Glipizide	Glipizide	39	11
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	38	12
Ibuprofen	Ibuprofen	38	30
Memantine Hcl	Memantine Hcl	37	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Pregabalin	Pregabalin	37	13
Ezetimibe	Ezetimibe	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	15
Meclizine Hcl	Meclizine Hcl	35	suppressed
Atenolol	Atenolol	34	suppressed
Humalog Kwikpen U-100	Insulin Lispro	33	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	32	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Allopurinol	Allopurinol	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Roflumilast	Roflumilast	29	suppressed
Azithromycin	Azithromycin	28	21
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	27	18
Labetalol Hcl	Labetalol Hcl	27	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	26	suppressed
Ofloxacin	Ofloxacin	25	22
Arnuity Ellipta	Fluticasone Furoate	24	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Cilostazol	Cilostazol	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	14
Nystatin	Nystatin	22	suppressed
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Ammonium Lactate	Ammonium Lactate	21	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Spiriva Handihaler	Tiotropium Bromide	21	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Enulose	Lactulose	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Single Use Swab	Alcohol Antiseptic Pads	19	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	18	suppressed
Sertraline Hcl	Sertraline Hcl	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Folic Acid	Folic Acid	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Vascepa	Icosapent Ethyl	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Alprazolam	Alprazolam	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Calcitriol	Calcitriol	15	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Mupirocin	Mupirocin	15	14
Naproxen	Naproxen	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	14	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Minoxidil	Minoxidil	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Colchicine	Colchicine	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	11	suppressed
Linzess	Linaclotide	11	suppressed
Nyamyc	Nystatin	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
True Comfort Safety Pen Needle	Pen Needle, Diabetic, Safety	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error